Allarity Therapeutics ALLR Ratios (2020-2026)

NASDAQ ALLR
$1.43 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-11,016.00%
EBIT Margin (Quarter)
-10,752.00%
EBITDA Margin (Quarter)
-10,752.00%
Operating Margin (Quarter)
-10,752.00%
Net Margin (Quarter)
-11,016.00%
FCF Margin (Quarter)
-18,256.00%
Efficiency
Assets Average (Quarter)
37.88M43.31M40.46M27.26M20.68M16.34M13.62M13.06M13.65M12.87M11.92M21.43M25.63M21.51M26.19M25.47M21.00M19.53M26.59M
Invested Capital (Quarter)
2.67M2.64M2.69M0.25M20.08M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-1.84-147.19-655.92-469.46-6.13-130.34-33.25-39.87-29.27-130.18-21.21-41.57-7.91-246.2619.36-53.26-344.42-44.18-39.43-11.74
Debt Ratio (Quarter)
0.050.180.210.030.030.020.57
Times Interest Earned (Quarter)
-1.84-147.19-655.92-469.46-6.13-130.34-33.25-39.87-29.27-130.18-21.21-41.57-7.91-246.2619.36-53.26-344.42-44.18-39.43-11.74
Valuation
Enterprise Value (Quarter)
-6.60M-5.58M-19.27M-14.54M-7.68M-3.95M-0.08M2.47M-0.42M-1.40M-0.22M-0.31M-19.23M-18.46M-0.07M-27.70M-16.89M-14.69M-29.81M
Return Ratios
Return on Sales (Quarter)
-1.10%
Return on Capital Employed (Quarter)
-39.17%-117.54%-152.79%-271.34%-562.34%-673.50%-974.05%-4,832.32%907.57%1,319.14%290.54%-156.48%-136.16%-255.19%-172.10%-163.12%-139.20%-113.59%867.75%
Return on Invested Capital (Quarter)
-0.10%-0.13%-0.15%-0.15%-0.16%-0.12%-0.03%-0.03%-0.09%-0.53%-0.84%
Return on Assets (Quarter)
0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%0.00%0.00%0.00%0.00%-0.01%0.00%